208 related articles for article (PubMed ID: 14997058)
81. Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study.
Maclaughlan David S; Salzillo S; Bowe P; Scuncio S; Malit B; Raker C; Gass JS; Granai CO; Dizon DS
BMJ Open; 2013 Sep; 3(9):e003138. PubMed ID: 24022390
[TBL] [Abstract][Full Text] [Related]
82. Patient- versus physician-reported outcomes in a low-dose tamoxifen trial in noninvasive breast cancer.
Buttiron Webber T; Marra D; Puntoni M; Giuliano S; Briata IM; Cevasco I; Clavarezza M; D'Amico M; Defferrari C; Gozza A; Provinciali N; Lazzeroni M; Bonanni B; DeCensi A
Breast J; 2021 Nov; 27(11):817-823. PubMed ID: 34626060
[TBL] [Abstract][Full Text] [Related]
83. Tamoxifen-induced radiation recall dermatitis.
Singer EA; Warren RD; Pennanen MF; Collins BT; Hayes DF
Breast J; 2004; 10(2):170-1. PubMed ID: 15009054
[No Abstract] [Full Text] [Related]
84. Tamoxifen-associated skin reactions in breast cancer patients: from case report to literature review.
Andrew P; Valiani S; MacIsaac J; Mithoowani H; Verma S
Breast Cancer Res Treat; 2014 Nov; 148(1):1-5. PubMed ID: 25292419
[TBL] [Abstract][Full Text] [Related]
85. Traditional Korean medicine treatment for tamoxifen associated adverse events of breast cancer patient: A CARE - Compliant case report.
Seo J; Lee D; Jo HG
Complement Ther Clin Pract; 2021 May; 43():101378. PubMed ID: 33845285
[TBL] [Abstract][Full Text] [Related]
86. Changes in hot flash experiences and related factors in women with breast cancer.
Li CY; Lin YC; Yang TY; Chen SC; Chang HK; Shen WC; Chen ML
Menopause; 2020 May; 27(5):535-542. PubMed ID: 32068690
[TBL] [Abstract][Full Text] [Related]
87. Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study.
Preece PE; Wood RA; Mackie CR; Cuschieri A
Br Med J (Clin Res Ed); 1982 Mar; 284(6319):869-70. PubMed ID: 6802332
[No Abstract] [Full Text] [Related]
88. Management of hot flashes in women with breast cancer.
Kligman L; Younus J
Curr Oncol; 2010 Feb; 17(1):81-6. PubMed ID: 20179808
[TBL] [Abstract][Full Text] [Related]
89. Relatively high doses of gabapentin might be as good as estrogen in relieving hot flashes.
Loprinzi CM
Curr Oncol Rep; 2007 Jul; 9(4):275. PubMed ID: 17588351
[No Abstract] [Full Text] [Related]
90. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
[TBL] [Abstract][Full Text] [Related]
91. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
92. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
Loprinzi CL; Dueck AC; Khoyratty BS; Barton DL; Jafar S; Rowland KM; Atherton PJ; Marsa GW; Knutson WH; Bearden JD; Kottschade L; Fitch TR
Ann Oncol; 2009 Mar; 20(3):542-9. PubMed ID: 19129205
[TBL] [Abstract][Full Text] [Related]
93. Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E.
Biglia N; Sgandurra P; Peano E; Marenco D; Moggio G; Bounous V; Tomasi Cont N; Ponzone R; Sismondi P
Climacteric; 2009 Aug; 12(4):310-8. PubMed ID: 19415540
[TBL] [Abstract][Full Text] [Related]
94. A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.
Lavigne JE; Heckler C; Mathews JL; Palesh O; Kirshner JJ; Lord R; Jacobs A; Amos E; Morrow GR; Mustian K
Breast Cancer Res Treat; 2012 Nov; 136(2):479-86. PubMed ID: 23053645
[TBL] [Abstract][Full Text] [Related]
95. Hot flashes in palliative care. Part 2 #262.
Lefkowits CC; Arnold RM
J Palliat Med; 2013 Jan; 16(1):101-2. PubMed ID: 23317326
[No Abstract] [Full Text] [Related]
96. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB.
Moraska AR; Atherton PJ; Szydlo DW; Barton DL; Stella PJ; Rowland KM; Schaefer PL; Krook J; Bearden JD; Loprinzi CL
J Support Oncol; 2010; 8(3):128-32. PubMed ID: 20552926
[TBL] [Abstract][Full Text] [Related]
97. Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial.
Butt DA; Lock M; Lewis JE; Ross S; Moineddin R
Menopause; 2008; 15(2):310-8. PubMed ID: 17917611
[TBL] [Abstract][Full Text] [Related]
98. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.
L'Espérance S; Frenette S; Dionne A; Dionne JY;
Support Care Cancer; 2013 May; 21(5):1461-74. PubMed ID: 23435567
[TBL] [Abstract][Full Text] [Related]
99. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.
Loprinzi CL; Kugler JW; Barton DL; Dueck AC; Tschetter LK; Nelimark RA; Balcueva EP; Burger KN; Novotny PJ; Carlson MD; Duane SF; Corso SW; Johnson DB; Jaslowski AJ
J Clin Oncol; 2007 Jan; 25(3):308-12. PubMed ID: 17146104
[TBL] [Abstract][Full Text] [Related]
100. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial.
Reddy SY; Warner H; Guttuso T; Messing S; DiGrazio W; Thornburg L; Guzick DS
Obstet Gynecol; 2006 Jul; 108(1):41-8. PubMed ID: 16816054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
